Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2021

View Archived Issues

Urinary follistatin useful to monitor AKI severity

Researchers develop a cystic fibrosis-related diabetes murine model

Roche describes new cyclic GMP-AMP synthase inhibitors

Janssen identifies NLRP3 inflammasome inhibitors

New GTPase KRAS mutant inhibitors discovered at Incyte

Aryl hydrocarbon receptor modulators discovered at Dong-A ST

New JAK inhibitors patented by Gossamer Bio

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Novel UOX-iKO mouse as model of hyperuricemia

RBT-9 shown effective against BK virus infection

STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Antibody discovery platform increases cancer immunotherapy targets

Studies of KL-11743 detail potential oncolytic activity of glucose transporter inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.